Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Pharmaceutically acceptable salt of EGFR inhibitor, crystal form thereof, preparation method therefor and application thereof

US Patent 10759797 · Granted Sep 1, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →